Niagen Bioscience subsidiary hires Red Sky Partners for advisory
Niagen Bioscience, Inc. (NASDAQ: NAGE) says its wholly owned subsidiary, NAD Pharmaceuticals Corp., has engaged Red Sky Partners, a life sciences strategic advisory firm, to support a drug development program and strategic business growth.